|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
5/18/2012 7:52:39 AM
Kleiner Perkins Caufield & Byers, one of the old-line giants of the venture capital industry, has closed its 15th traditional fund at $525 million, the firm announced late on Thursday. The fund, known as KPCB 15, will have a wide mandate, including investments in consumer and enterprise Internet start-ups, green technology and life sciences companies. It will be led by 10 of Kleiner Perkins’ partners. “Portfolio companies in KPCB 15 will benefit from the firm’s holistic approach to company building that we pioneered more than a decade ago,” Ted Schlein, a Kleiner Perkins partner, said in a statement.
|
|
|
|
|
|
|
|
|
|
|